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Background-—Whether the remote myocardium of reperfused ST-segment elevation myocardial infarction (STEMI) patients plays a
part in adverse left ventricular (LV) remodeling remains unclear. We aimed to use automated extracellular volume fraction (ECV)
mapping to investigate whether changes in the ECV of the remote (ECVRemote) and infarcted myocardium (ECVInfarct) impacted LV
remodeling.
Methods and Results-—Forty-eight of 50 prospectively recruited reperfused STEMI patients completed a cardiovascular magnetic
resonance at 42 days and 40 had a follow-up scan at 52 months. Twenty healthy volunteers served as controls. Mean
segmental values for native T1, T2, and ECV were obtained. Adverse LV remodeling was deﬁned as ≥20% increase in LV end-
diastolic volume. ECVRemote was higher on the acute scan when compared to control (27.92.1% vs 26.42.1%; P=0.01). Eight
patients developed adverse LV remodeling and had higher ECVRemote acutely (29.51.4% vs 27.42.0%; P=0.01) and remained
higher at follow-up (28.61.5% vs 26.62.1%; P=0.02) compared to those without. Patients with a higher ECVRemote and a lower
myocardial salvage index (MSI) acutely were signiﬁcantly associated with adverse LV remodeling, independent of T1Remote, T1Core
and microvascular obstruction, whereas a higher ECVInfarct was signiﬁcantly associated with worse wall motion recovery.
Conclusions-—ECVRemote was increased acutely in reperfused STEMI patients. Those with adverse LV remodeling had higher
ECVRemote acutely, and this remained higher at follow-up than those without adverse LV remodeling. A higher ECVRemote and a lower
MSI acutely were signiﬁcantly associated with adverse LV remodeling whereas segments with higher ECVInfarct were less likely to
recover wall motion. ( J Am Heart Assoc. 2016;5:e003555 doi: 10.1161/JAHA.116.003555)
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A lthough mortality after an acute ST-elevation myocardialinfarction (STEMI) is in decline, the onset of post–
myocardial infarct (MI) heart failure is still signiﬁcant.1–3 MI
size,4,5 presence of microvascular obstruction (MVO),6,7 and
myocardial salvage8,9 assessed by cardiovascular magnetic
resonance (CMR) performed in the ﬁrst few days after
reperfusion in STEMI patients have all been shown to be
strong predictors of adverse left ventricular (LV) remodeling
and development of heart failure.
Whether changes in the extracellular matrix (ECM) in the
noninfarcted remote myocardium in STEMI patients reper-
fused by primary percutaneous coronary intervention (PPCI) is
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linked to adverse LV remodeling remains incompletely
understood.10–14 Although native T1 mapping14 and postcon-
trast T1 mapping13 CMR have been used to interrogate
remote myocardial ECM, the availability of automated extra-
cellular volume fraction (ECV) mapping CMR provides a more
robust method for quantifying not only focal ﬁbrosis, but also
diffuse interstitial expansion in the myocardium15,16 given
that native and postcontrast T1 maps are coregistered and
motion corrected, thereby improving the quality of the
generated automated maps.17
Using the latest coregistered and motion-corrected T1
mapping technology to create accurate automated ECV maps,
we set out to investigate, ﬁrst, whether changes in ECV in the
remote myocardium occurred in the current era and whether
they were associated with adverse LV remodeling and,
second, whether ECV of the infarct zone was a better
predictor of wall motion recovery than transmural extent of
the infarct after reperfused STEMI.
Methods
Study Population
This was a prospective, single-center study of acute STEMI
patients reperfused by PPCI. Fifty patients were recruited over
a 12-month period, and 20 age- and sex-matched healthy
volunteers served as control (all free of cardiovascular
disease). All participants were scanned at the same center
and on the same scanner. Diagnosis and treatment of STEMI
were as per current guidelines.18,19 Study exclusion criteria
were previous MI and standard recognized contraindications
to CMR (eg, ferromagnetic implants, claustrophobia, and
estimated glomerular ﬁltration rate <30 mL/min). All patients
provided informed written consent. The UK National Research
Ethics Service approved this study.
Imaging Acquisition
All CMR scans were performed on a 1.5 Tesla scanner
(MAGNETOM Avanto; Siemens Medical Solutions, Malvern,
PA) using a 32-channel phased-array cardiac coil.
Imaging protocol
In the STEMI cohort, all patients had T2 maps acquired from
base to apex during the acute scan. As for native T1 and
postcontrast T1 maps, 30 patients had whole LV short-axis
coverage and the remaining 10 had 3 (basal, mid, and apical)
LV short-axis T1 maps acquired during both scans. The 20
healthy volunteers had 1 midventricular short-axis native T1,
T2, and postcontrast T1 maps acquired. All participants had
whole heart coverage LV short-axis cines and late gadolinium
enhancement (LGE) acquired.
Native T1 mapping
T1 maps (Work In Progress 448B; Siemens Healthcare,
Erlangen, Germany) were acquired using a steady state free
precession (SSFP)-based modiﬁed look-locker inversion recov-
ery (MOLLI) sequence. A 5s(3s)3s modiﬁed MOLLI sampling
protocol was used to ensure more-complete recovery of the
inversion pulse at higher heart rates by acquiring a set of
images for at least 5 seconds after the ﬁrst inversion pulse,
followed by a 3-second pause and then acquiring a set of
images after the second inversion pulse for at least 3 sec-
onds.20 The acquisition parameters were: pixel bandwidth,
977 Hz/pixel; echo time=1.1 ms; ﬂip angle=35 degrees;
matrix=2569144; and slice thickness=6 mm. Motion correc-
tion and a nonlinear least-square curve ﬁtting were performed
with the set of images acquired at different inversion times to
generate a pixel-wise colored T1 map by the scanner.
T2 mapping
T2 maps (Work In Progress 448B; Siemens Healthcare,
Erlangen, Germany) were acquired as previously described.21
In brief, 3 single-shot images at different T2 preparation times
(0, 24, and 55 ms, respectively) using the following param-
eters were acquired: pixel bandwidth, 930 Hz/pixel; echo
time=1.1 ms; repetition time=39 R-R interval; ﬂip angle=70
degrees; acquisition matrix=1169192; and slice thick-
ness=6 mm. A colored T2 map consisting of pixel-wise T2
values was generated after ﬁtting to estimate T2 relaxation
times and motion correction by the scanner.
Late gadolinium enhancement
LGE imaging was acquired with a standard segmented “fast
low-angle shot” 2-dimensional inversion-recovery gradient
echo sequence or a respiratory motion-corrected, free-
breathing, single-shot, SSFP-averaged, phase-sensitive inver-
sion recovery sequence22,23 at 10 to 15 minutes after the
injection of 0.1 mmol/kg of gadoterate meglumine (Gd-DOTA
marketed as Dotarem; Guerbet S.A., Paris, France).
Postcontrast T1 mapping
Postcontrast T1 maps (Work In Progress 448B; Siemens
Healthcare, Erlangen, Germany) were obtained using the 4s
(1s)3s(1s)2s sampling protocol (to improve the accuracy of T1s
in the 200- to 600-ms range as previously described20)
15 minutes after contrast injection (0.1 mmol/kg of Dotarem)
using similar acquisition parameters as for native T1 maps.
ECV maps
The previously described and validated automated method for
producing a pixel-wise ECV map was used.17 In brief, this
method corrects for respiratory motion attributed to poor
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breath holding as well as patient movement between breath
holds and relies on coregistration of the native and postcon-
trast T1 pixel maps. Each patient had hematocrit checked at
the time of the scan and the ECV was estimated using the
following formula24:
ECV ¼ (1-hematocrit)
 ð1=T1myocardium postÞ  ð1=T1myocardium preÞð1=T1blood postÞ  ð1=T1blood preÞ
An ofﬂine software (ECV Mapping Tool, Version 1.1)
subsequently generated pixel-wise ECV maps using a variety
of postprocessing steps as recently described.17
Imaging Analysis
All imaging analysis was performed using CVI42 software
(version 5.1.2[303]; Circle Cardiovascular Imaging, Calgary,
Alberta, Canada).
Wall motion analysis
Segmental wall motion on the short-axis cine images were
visually scored by 2 experienced investigators (H.B., S.R.) as “0”
for normal; “1” for mild/moderate hypokinesis; “2” for severe
hypokinesis; “3” for akinesis; and “4” dyskinesis25 and displayed
as per the 16-segment American Heart Association (AHA)
classiﬁcation.26 Wall motion recovery was deﬁned as an
improvement in wall motion score by 1. Segmental wall end-
diastolic and end-systolic wall thickness, wall thickening, and
wall motion were derived from averaging the mean thicknesses
from 100 chords for each short-axis slice, covering the whole LV,
and also displayed as per the modiﬁed 16-segment AHA model.
MI and area-at-risk quantiﬁcation
MI size was quantiﬁed using a threshold of 5 SDs27 above the
mean remote myocardium and expressed as a percentage of
the LV. The area-at-risk (AAR) was assessed from the T2 maps
using a threshold of 2 SDs above the mean remote
myocardium and expressed a percentage of the whole
LV.28,29 Areas of hypointense core of MVO were included as
part of the MI zone, and AAR and MVO from the LGE images
were quantiﬁed and expressed in grams. Transmural extent of
LGE was expressed by averaging the values from 100 chords
from each short-axis slice to obtain the mean transmural extent
of LGE for each of the 16 AHA segments. Figure 1 shows an
example of a mid-LV short-axis ECV map of an acute anterior
STEMI with MVO and the corresponding follow-up ECV map.
Analysis of the T1, T2, and ECV maps
Endocardial and epicardial borders were manually delineated
on the native T1 maps and T2 maps and copied on the ECV
maps. The left ventricular outﬂow track and apical LV short-
axis slices were excluded, and a 10% erosion of the wall
thickness was applied to the endocardial and epicardial
borders to minimize partial volume effects. Mean segmental
T1, T2, and ECV values were then generated and displayed as
bull’s-eye plots using the 16 AHA segments (Figure 2). For
assessing intermethod agreement, manual regions of interest
(ROIs) were also drawn with care to avoid partial volume
effects in the remote myocardium and infarcted segments of
10 patients for comparison with mean segmental values for
ECV. The remote myocardium was deﬁned as the AHA
segment 180 degrees from the infarct territory with normal
wall motion and no LGE. T1, T2, and ECV values in the remote
myocardium were represented by T1Remote, T2Remote, and
ECVRemote. T1 values of the core (T1Core) of the infarct was
obtained by manually drawing the ROI within the hypoen-
hanced regions inside areas of hyperenhancement within
2 SDs of the remote myocardium on the T1 maps and are
represented as T1Core. Mean segmental ECV of the infarcted
segments is represented as ECVInfarct. Adverse LV remodeling
was deﬁned as a ≥20% increase in end-diastolic volume (EDV)
between the acute and follow-up scans.14
Statistical Analysis
Statistical analysis was performed using SPSS software
(version 22; IBM Corp, Chicago, IL). Test for normality was
performed using the Shapiro–Wilk Test. Continuous data are
expressed as meanSD or median (interquartile range) and
compared with the paired Student t test/Wilcoxon signed-
rank test or unpaired Student t test/Mann–Whitney U test,
where appropriate. Categorical data are reported as frequen-
cies and percentages. Interobserver and intraobserver vari-
ability for ECVRemote and ECVInfarct was assessed in 10
patients and expressed as intraclass correlation coefﬁcient
(ICC) and 95% CI and bias 2 SDs (for limits of agreement)
using Bland–Altman analysis. Receiver operating characteris-
tic (ROC) analyses were performed to assess the diagnostic
performance for LGE, T1, T2, and ECV on the acute scan for
predicting segmental wall motion recovery for the AHA
segments with LGE, and this was repeated for segments with
LGE, but without MVO. Univariable and multivariable linear
regression analyses were also performed to identify associ-
ates of adverse remodeling. To take into consideration
potential within-subject interaction of some segments
with the independent variables, R software (version 3.2.3;
R Foundation for Statistical Computing, Vienna, Austria;
available at: http://www.R-project.org/) was used for clus-
tered ROC analysis by the method described by Obuchowski30
to assess the performance of T1, T2, ECV, and LGE to predict
wall motion recovery, and a linear mixed-effects model was
used to identify predictors of segmental wall motion recovery
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after adjusting interaction among segments within the same
patients. All statistical tests were 2-tailed, and P<0.05 was
considered statistically signiﬁcant.
Results
Figure 3 illustrates the STEMI patients’ screening and
recruitment process. Of 50 STEMI patients recruited into
the study, 48 completed the ﬁrst CMR at 42 days post-PPCI
and 40 had a follow-up scan at 52 months (2 patients did
not complete the scan because of unexpected claustrophobia,
8 were lost to follow-up). There was no difference in the main
acute CMR characteristics apart from a higher EDV between
the 40 patients who had paired acute and follow-up scans and
those who only had the acute scan, as shown in Table 1.
Mean age of STEMI patients was 5913 years, and 88% were
male. Further details regarding patient characteristics are
listed in Table 2. Mean age of healthy volunteers was
6010 years, and 90% were male. A total of 10% of the T1,
T2, and ECV maps had to be excluded from the analysis
because of artifacts, partial volume effects, and/or being
nondiagnostic, as previously described.17
As expected, LV EDV and end-systolic volume (ESV) were
signiﬁcantly higher for STEMI patients (on both the acute and
follow-up scans) when compared to the controls (Table 3),
although there was no signiﬁcant difference in LV mass. Mean
MI size in STEMI patients was 27.414.6% of the LV, and
mean AAR was 42.012.0% of the LV, giving a mean
myocardial salvage index (MSI) of 0.370.27 of the LV. As
expected, there was a signiﬁcant regression in MI size
between the acute scan and the follow-up scan (27.414.6%
to 19.510.5%; P<0.001). Twenty-six of 40 (65%) of the
included patients had MVO.
Intraobserver and Interobserver Variability for
ECV Measurements
There was less intraobserver and interobserver variability
when ECVRemote and ECVInfarct were assessed by mean
segmental analysis when compared to manual ROI (Table 4).
Figure 1. Example of LGE images and ECV maps of an acute and follow-up scan of a patient with an
anterior STEMI. The arrows show the area of LGE with a core of MVO on the acute scan and the
corresponding chronic LGE and ECV. ECV indicates extracellular volume fraction; LGE, late gadolinium
enhancement; MVO, microvascular obstruction; STEMI, ST-segment elevation myocardial infarction.
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For intraobserver measurements, the limits of agreement for
ECVRemote were 1.22% when using mean segmental values
compared to 1.59% when using manual ROI. For interob-
server measurements, the limits of agreement for ECVRemote
were 0.99% when using mean segmental values compared
to 1.40% when using manual ROI. The limits of agreement
for the two techniques were even wider for ECVInfarct
(Table 4).
Changes in the Remote Myocardium
For both the acute and follow-up scans, there were no
differences in LV diastolic and systolic wall thickness and LV
wall thickening in the remote myocardium between STEMI
patients and controls (Table 3). However, on the acute scan,
LV wall motion in the remote myocardium was higher in
STEMI patients when compared to controls (9.22.6 vs
7.72.5 mm; P=0.04), but there was no statistically signif-
icant difference between them on the follow-up scan
(8.92.6 vs 7.72.5 mm; P=0.10; Table 4).
There were no signiﬁcant differences in the T2Remote values
between STEMI patients and controls on either the acute scan
or the follow-up scans. Native T1Remote and ECVRemote were
both signiﬁcantly higher in STEMI patients when compared to
controls on the acute scan (T1: 103251 vs 100025 ms;
P=0.001; ECV: 27.92.1% vs 26.42.1%; P=0.01), but this
difference was not present on the follow-up scan
(T1: 100439 vs 100025 ms; P=0.66; ECV: 27.02.1%
vs 26.42.1%; P=0.30; Table 3).
LV Remodeling
Of 40 STEMI patients who had a follow-up scan, 8 (20%)
patients had adverse LV remodeling. In these 8 patients, the
ECVRemote was higher acutely when compared to those 32
without adverse LV remodeling (29.51.4% vs 27.42.0%;
P=0.01), and this difference in ECVremote persisted on the
follow-up scan (28.61.5% vs 26.62.1%; P=0.02). There
were no signiﬁcant differences in T2Remote between those with
and without adverse LV remodeling both on the acute and
follow-up scans (Figure 4).
Multiparametric CMR Prediction of Remodeling
A percentage increase in LV EDV as a continuous variable was
used as a surrogate for adverse LV remodeling for univariable
and multivariable linear regression analysis. MI size quantiﬁed
by LGE (R2=0.36; coefﬁcient, 0.64; 95% CI, 0.37–0.9;
P=0.0001) was the single most signiﬁcant predictor of
adverse LV remodeling after adjusting for remote myocardial
Figure 2. Example of generated bull’s eye plots with AHA segments from the maps and LGE images. AHA
indicates American Heart Association; ECV, extracellular volume fraction; LGE, late gadolinium enhance-
ment.
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T1, MVO, and LV EDV on the acute scan in a multivariable
analysis. In order to account for both MI size and AAR, MSI
was used in the regression model instead of MI size. T1Remote
and ECVRemote, T1Core, MSI, and MVO on the acute scan were
signiﬁcantly associated with adverse LV remodeling on
univariable analysis, and these were then included in a
multivariable analysis. MSI and then ECVRemote were most
associated with adverse LV remodeling after adjusting for
T1Remote, T1Core and MVO on the acute scan (Table 5).
ECV and Segmental Recovery of LV Systolic
Function
Two hundred sixty-three of 640 segments had LGE and
abnormal wall motion. The mean ECVInfarct of all segments
with LGE on the acute scan was 50.59.4%. MVO was present
in 77 of these 263 segments, and it was negatively associated
with segmental LV wall motion recovery after adjusting for
transmural extent of LGE and for the interaction between
segments with MVO and patients (77 segments; only 24%
recovered; P<0.001; R2=0.80). Because gadolinium contrast
failed to reach pseudoequilibrium in areas of MVO, analysis for
segmental LV wall motion recovery was performed with and
without segments containing MVO. ECVInfarct was performed as
well as transmural extent of LGE on clustered ROC curve
analysis (area under the curve [AUC], 0.68; 95% CI, 0.59–0.77
vs 0.72; 95% CI, 0.64–0.80; P=0.23 for comparison of both
ROC curves), whereas mean segmental T1 and T2 were not
good tests to predict improvement in segmental LV wall motion
(T1: AUC, 0.45; 95% CI, 0.37–0.54; P=0.60; T2: AUC, 0.54; 95%
CI, 0.44–0.64; P=0.15). After excluding segments with MVO
(77 segments), this relationship was maintained between
ECVInfarct and transmural extent of LGE (AUC, 0.63; 95% CI,
0.52–0.73 vs 0.63; 95% CI, 0.53–0.73; P=0.89 for ROC curve
comparison). A lower ECVInfarct was found to be a signiﬁcant
predictor of wall motion recovery after adjusting for transmural
extent of LGE and interaction among segments within the same
patients (P=0.039; R2=0.48).
Discussion
The major ﬁndings of this study were as follows: (1) We
showed that ECVRemote in STEMI patients is acutely elevated,
and this elevation persisted in those STEMI patients that
developed adverse remodeling at 5 months; (2) MSI and
ECVRemote in the remote myocardium were most associated
with adverse LV remodeling after adjusting for T1Remote,
T1Core, and MVO on the acute scan; and (3) ECVInfarct was
found to be a signiﬁcant predictor of LV wall motion recovery
after adjusting for transmural extent of LGE.
Figure 3. STEMI patients screening and recruitment ﬂow chart. CMR indicates cardiovascular magnetic
resonance imaging; STEMI, ST-segment elevation myocardial infarction.
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There was no statistical difference in T2 values that were
observed in the remote myocardium of STEMI patients when
compared to controls, suggesting that the increased ECV was
probably not attributed to myocardial edema, although there
was a trend toward the T2Remote values of STEMI patients
being higher. There is a possibility that it may have been
attributed to an expansion of the intravascular compartment
from increased myocardial blood ﬂow associated with the
compensatory increase in LV wall motion observed in the
remote myocardium.
Of note, this increase in ECVRemote only persisted in those
STEMI patients who went on to develop adverse LV remodeling.
In a murine model of acute MI, Tsuda et al.11 found molecular
and immune-histochemical evidence of interstitial ﬁbrosis in the
remote myocardium as early as 72 hours post-MI. Volders
et al.10 provided postmortem histological evidence of an
increase in interstitial collagen in the remote myocardium of
infarcted patients when compared to control. It may be possible
that the increase in ECVRemote in this subset of patients
represent early interstitial ﬁbrosis. However, Marijianowski
et al.12 showed that post-MI LV remodeling in patients with
end-stage heart failure undergoing transplant was not associ-
ated with interstitial ﬁbrosis in the remote myocardium.
Chan et al.13 used postcontrast T1 in 25 acute STEMI
patients and found evidence of early remote systolic
dysfunction and expansion of the ECM, which persisted in
Table 1. Acute CMR Characteristics Between Patients Who
Completed Paired Acute and Follow-up Scans (n=40) and
Patients Who Only Had the Acute Scan (n=8)
Patients With
Paired CMR
(n=40)
Patients With
Acute CMR
Only (n=8) P Value
Acute LV EDV, mL 17238 13528 0.01*
Acute indexed
LV EDV, mL/m2
8713 7313 0.01*
Acute LV ESV, mL 9030 6620 0.04*
Acute indexed
LV ESV, mL/m2
4513 3611 0.07
Acute LV EF, % 498 528 0.32
Acute LV mass, g 111 (92–124) 137 (86–154) 0.28
Acute MI size,
% of LV
28 (14.8–38.0) 24.0 (23.0–25.8) 0.52
AAR, % of LV 42.012.0 46.410.9 0.34
MVO, % 26 (65%) 5 (63%) 0.60
Acute T2Remote,
ms
50 (48–52) 49 (48–54) 0.78
Acute T1Remote,
ms
1026 (990–1077) 1043 (963–1095) 0.80
Acute ECVRemote, % 28.1 (26.2–29.7) 27.6 (26.2–31.2) 0.73
AAR indicates area-at-risk; CMR, cardiovascular magnetic resonance imaging; EDV, end
diastolic volume; EF, ejection fraction; ESV, end systolic volume; LV, left ventricle; MVO,
microvascular obstruction.
*Denotes statistical signiﬁcance at P<0.05.
Table 2. Clinical Characteristics of STEMI Patients (n=40)
Details No.
No. of patients 40
Male (%) 35 (88)
Age, y 5913
Diabetes mellitus (%) 8 (20)
Hypertension (%) 14 (35)
Smoking (%) 12 (30)
Dyslipidemia (%) 14 (35)
Chest pain onset to PPCI time, min 267 [122–330]
Infarct artery (%)
LAD 24 (60)
RCA 14 (35)
Cx 2 (5)
Pre-PPCI TIMI flow (%)
0 33 (83)
1 0 (0)
2 3 (8)
3 4 (10)
Post-PPCI TIMI flow (%)
0 1 (3)
1 0 (0)
2 8 (20)
3 31 (77)
Treatment—during PPCI (%)
Aspirin 100 (100)
Clopidogrel 24 (60)
Ticagrelor 16 (40)
Heparin 36 (90)
Bivalirudin 11 (28)
Glycoprotein IIbIIIa inhibitors 11 (28)
Treatment—on discharge (%)
Dual antiplatelet therapy 40 (100)
Beta-blockers 40 (100)
ACEI/ARB 40 (100)
Statin 39 (98)
MRA 10 (25)
ACEI/ARB indicates angiotensin-converting enzyme inhibitor/angiotensin receptor
blocker; Cx, circumﬂex artery; LAD, left anterior descending artery; MRA,
mineralocorticoid receptor antagonist; PPCI, primary percutaneous coronary
intervention; RCA, right coronary artery; STEMI, ST-segment elevation myocardial
infarction; TIMI, thrombolysis in myocardial infarction.
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the chronic stage, and their ﬁndings partly differ from ours.
We did not ﬁnd evidence of systolic dysfunction in the remote
myocardium, but, paradoxically, found an increase in wall
motion in the remote myocardium in the acute scan only.
These differences may partly be attributed to the smaller
number of patients and methodology used in their study
(deﬁnition of a remote sector: any segment without LGE as
deﬁned in their study may potentially include adjacent
segments with edema and stunning; they only analyzed base,
mid, and an apical cine compared to whole-LV short-axis
analysis and using averaged values of the midventricular
segments in our study). Furthermore, not all STEMI patients
showed persistence of ECVRemote expansion at follow-up when
using automated ECV maps and may be attributed to the fact
that we included more patients with a wider range of MI size
as a percentage of the LV (acute MI size in our study
27.414.6% vs 19.210.5% in their study) and the higher use
of angiotensin-converting enzyme inhibitors/angiotensin
receptor blockers (ACEI/ARB) and mineralocorticoid receptor
antagonist (MRA) in our study (ACEI/ARB, 92% vs 100%: MRA,
16% vs 25%).
Carrick et al.14 demonstrated that increased native T1
values in remote myocardium of reperfused STEMI patients
were independently associated with adverse LV remodeling
Table 3. CMR Findings (n=40 STEMI Patients and n=20 Controls)
Controls
(n=20)
Acute
Scan (n=40)
Follow-up
Scan (n=40)
Change Between
Acute and Follow-up P Value
LV EDV, mL 14834 17238 18249 925 0.02*
0.01†
LV ESV, mL 5516 9030 8838 224 0.001*
0.001†
LV EF, % 635 498 5310 58 0.001*
0.001†
LV mass, g 10821 11235 10426 827 NS
LV wall thickness in remote myocardium—diastole, mm 7.20.7 7.11.3 6.71.3 0.41.3 NS
LV wall thickness in remote myocardium—systole, mm 12.01.3 12.01.8 11.21.8 0.82.3 NS
LV wall thickening in remote myocardium, % 6614 7740 7526 243 NS
LV wall motion in remote myocardium, mm 7.72.5 9.22.6 8.92.6 0.32.9 0.04*
0.10†
Infarct size, % of LV NA 27.414.6 19.510.5 7.97.2 0.0001
Infarct size, g NA 20.213.6 14.49.4 5.85.9 0.0001
AAR, % of LV NA 42.012.0 NA NA
T2Remote, ms 504 503 482 13 0.94*
0.001†
T2Infarct, ms NA 655 575 97 0.0001
T2Core, ms NA 515 473 45 0.001
T1Remote, ms 100025 103251 100439 2952 0.001*
0.66†
T1Infarct, ms NA 124575 114153 10488 0.0001
T1Core, ms NA 102589 102952 579 0.74
ECVRemote, %
Whole cohort (n=40) 26.42.1 27.92.1 27.02.1 0.91.9 0.01*
0.30†
With adverse LV remodeling (n=8) NA 29.51.4 28.61.5 0.92.2 0.27
Without adverse LV remodeling (n=32) NA 27.42.0 26.62.1 0.91.9 0.02
ECVInfarct, % NA 69.29.6 70.419.9 1.218.3 0.71
AAR indicates area-at-risk; CMR, cardiovascular magnetic resonance imaging; ECV, extracellular volume fraction; EDV, end diastolic volume; EF, ejection fraction; ESV, end systolic volume;
LV, left ventricle; MVO, microvascular obstruction; NA, not applicable; NS, not statistically signiﬁcant; STEMI, ST-segment elevation myocardial infarction.
*Control vs acute scan.
†
Control vs follow-up scan.
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after adjusting for LV EDV, MI size, and MVO on the acute
scan. In a separate publication, Carrick et al.31 also showed
that native T1 of the hypointense infarct core was inversely
associated with the risk of all-cause mortality or hospitaliza-
tion for heart failure in the same cohort of patients, although
they did not adjust for native T1 of the remote myocardium. In
contrast, in our cohort, we showed that MI size was the single
most signiﬁcant predictor of adverse LV remodeling after
adjusting for similar parameters, including native T1 of the
remote myocardium. Although MI size is known to be a strong
predictor of outcome,4,5 MSI is a more-sensitive marker to
assess the effectiveness of a reperfusion strategy32,33 in
randomized, controlled trials and it was recently shown that
MSI signiﬁcantly reduced sample size.34 Therefore, we opted
to use MSI instead of MI size expressed as a percentage of
the LV. We found that acute ECVRemote together with MSI were
also strongly associated with LV remodeling after adjusting
for both T1Remote and T1Core and MVO. There was no evidence
of edema of the remote myocardium by T2 mapping, even in
those patients who subsequently developed LV remodeling.
Although the sample size was smaller in our study, our
ﬁndings may also differ from the studies by Carrick et al.,14,31
given that we used mean segmental values for T1, T2, and
ECV rather than manual ROI (the ICC for reliability of remote
T1 in Carrick et al.14 was 0.92 and had quite a wide 95% CI
[0.80, 0.97]). Furthermore, the majority of our patients (>70%)
had whole LV coverage for the T1 maps, and ECV maps and
were averaged to derive the AHA segmental values and
therefore were more likely to be a better representation of the
changes in the remote myocardium.
For myocardial segments with LGE, ECVInfarct was as good
a predictor as transmural LGE for LV wall motion recovery. For
segments without MVO, ECVInfarct was a signiﬁcant predictor
of segmental LV systolic recovery after adjusting for LGE.
Given the heterogeneity of LGE, we chose to use mean
segmental ECV values to minimize sampling errors and partial
volume effects, and this approach may be a better reﬂection
of the ECV matching the corresponding transmural extent of
LGE per segment on both the acute and follow-up scan. The
Table 4. Intraobserver and Interobserver Variability for ECV
Using 2 Different Techniques (Mean Segmental Values and
Manual ROI; n=10)
Intraclass Correlation
Coefﬁcient (95% CI)
BiasLimits of
Agreement (%)
Intraobserver variability (n=10)
ECVRemote
Mean segmental values 0.994 (0.976–0.998) 0.111.22
Manual ROI 0.981 (0.922–0.995) 0.421.59
ECVInfarct
Mean segmental values 0.992 (0.967–0.998) 0.532.44
Manual ROI 0.972 (0.886–0.993) 0.135.02
Interobserver variability (n=10)
ECVRemote
Mean segmental values 0.996 (0.984–0.999) 0.100.99
Manual ROI 0.989 (0.958–0.997) 0.181.40
ECVInfarct
Mean segmental values 0.991 (0.949–0.998) 0.812.21
Manual ROI 0.963 (0.850–0.991) 0.105.96
ECV indicates extracellular volume fraction; ROI, region of interest.
Figure 4. T2 and ECV of the remote myocardium in STEMI
patients with (n=8) and without LV remodeling (n=32). ECV
indicates extracellular volume fraction; LV, left ventricular; STEMI,
ST-segment elevation myocardial infarction. *Denotes statistical
signiﬁcance at P<0.05.
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availability of ECV maps could provide further quantiﬁcation of
the infarct severity and complement transmural extent of LGE
to predict wall motion recovery.
Limitations
To our knowledge, this is the ﬁrst study to use automated ECV
maps in this setting, which is more accurate to assess changes
in myocardial extracellular volume17 and also the ﬁrst study to
investigate the changes occurring in the remote and infarct-
related segments by ECV in paired CMR scans of STEMI
patients performed acutely and after a follow-up of 5 months.
However, our study is not without limitations. We only included
a relatively small number of patients, and therefore we were
unable to determine the impact of changes in extracellular
volume on major adverse cardiovascular events. We did not
collect biochemical markers for inﬂammation, remodeling, and
ﬁbrosis to correlate with CMR ﬁndings.
Summary and Conclusions
ECVRemote was increased acutely in STEMI patients reperfused
by PPCI when compared to healthy controls. For those
patients who developed adverse LV remodeling, ECVRemote
acutely was higher than those who did not develop adverse LV
remodeling and remained persistently higher at follow-up.
Patients with higher ECVRemote and lower MSI acutely were
more likely to develop adverse LV remodeling, whereas
segments with higher ECVInfarct were less likely to have wall
motion recovery.
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